MRI based volumetric measurements of vestibular schwannomas in patients with neurofibromatosis type 2: comparison of three different software tools

被引:8
|
作者
Kollmann, Philipp [1 ]
Mautner, Victor-Felix [1 ]
Koeppen, Johannes [2 ]
Wenzel, Ralph [3 ]
Friedman, Jan M. [4 ]
Salamon, Johannes [5 ]
Farschtschi, Said [1 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Martinistr 52, D-20246 Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany
[3] Radiol Practice Altona, Hamburg, Germany
[4] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada
[5] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol & Nucl Med, Hamburg, Germany
关键词
BEVACIZUMAB;
D O I
10.1038/s41598-020-68489-y
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Neurofibromatosis type 2 is a neurogenetic disorder with an incidence of about 1:33.000. Hallmarks are bilateral benign vestibular schwannomas, which can lead to deafness or brainstem compression. Volumetric tumor measurements are essential to assess the efficacy of new therapies. We present a statistical and methodical comparison of three volumetric image analysis tools. We performed volumetric measurements on phantoms with predefined volumes (0.1 to 8.0 ml) and tumors seen on 32 head MRI scans from eight NF2 patients with BrainLab, ITK-Snap, or OsiriX. The software was compared with regard to accuracy and reproducibility of the measurements and time required for analysis. The mean volume estimated by all three software programs differed significantly from the true volume of the phantoms, but OsiriX and BrainLab gave estimates that were not significantly different from each other. For the actual tumors, the estimated volumes with all three software tools showed a low coefficient of variability, but the mean volume estimates differed among the tools. OsiriX showed the shortest analysis time. Volumetric assessment of MRI images is associated to an intrinsic risk of miscalculation. For precise volumes it is mandatory to use the same volumetric tools for all measurements.
引用
收藏
页数:9
相关论文
共 49 条
  • [1] MRI based volumetric measurements of vestibular schwannomas in patients with neurofibromatosis type 2: comparison of three different software tools
    Philipp Kollmann
    Victor-Felix Mautner
    Johannes Koeppen
    Ralph Wenzel
    Jan M. Friedman
    Johannes Salamon
    Said Farschtschi
    Scientific Reports, 10
  • [2] Comparing the sensitivity of linear and volumetric MRI measurements to detect changes in the size of vestibular schwannomas in patients with neurofibromatosis type 2 on bevacizumab treatment
    Morris, Katrina A.
    Parry, Allyson
    Pretorius, Pieter M.
    BRITISH JOURNAL OF RADIOLOGY, 2016, 89 (1065):
  • [3] DIFFERENT GROWTH PATTERN OF VESTIBULAR SCHWANNOMAS IN NEUROFIBROMATOSIS TYPE 2 PATIENTS ACCORDING TO AGE
    Kang, Ho
    Ji, So Young
    Hwang, Kihwan
    Kim, Chae-Yong
    Han, Jung Ho
    NEURO-ONCOLOGY, 2024, 26
  • [4] Radiosurgical Treatment of Vestibular Schwannomas in Patients with Neurofibromatosis Type 2
    Phi, Ji Hoon
    Kim, Dong Gyu
    Chung, Hyun-Tai
    Lee, Joongyub
    Paek, Sun Ha
    Jung, Hee-Won
    CANCER, 2009, 115 (02) : 390 - 398
  • [5] Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2
    Mautner, Victor-Felix
    Nguyen, Rosa
    Kutta, Hannes
    Fuensterer, Carsten
    Bokemeyer, Carsten
    Hagel, Christian
    Friedrich, Reinhard E.
    Panse, Jens
    NEURO-ONCOLOGY, 2010, 12 (01) : 14 - 18
  • [6] Strategy for the surgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2
    Nowak, Arkadiusz
    Dziedzic, Tomasz
    Czernicki, Tomasz
    Kunert, Przemyslaw
    Morawski, Krzysztof
    Niemczyk, Kazimierz
    Marchel, Andrzej
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2015, 49 (05) : 295 - 301
  • [7] Reduced dosage of bevacizumab in treatment of vestibular schwannomas in patients with neurofibromatosis type 2
    Said Farschtschi
    Philipp Kollmann
    Carsten Dalchow
    Alexander Stein
    Victor-Felix Mautner
    European Archives of Oto-Rhino-Laryngology, 2015, 272 : 3857 - 3860
  • [8] Reduced dosage of bevacizumab in treatment of vestibular schwannomas in patients with neurofibromatosis type 2
    Farschtschi, Said
    Kollmann, Philipp
    Dalchow, Carsten
    Stein, Alexander
    Mautner, Victor-Felix
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2015, 272 (12) : 3857 - 3860
  • [9] Identification of three neurofibromatosis type 2 (NF2) gene mutations in vestibular schwannomas
    Sainz, J
    Figueroa, K
    Baser, ME
    Pulst, SM
    HUMAN GENETICS, 1996, 97 (01) : 121 - 123
  • [10] Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis Type 2
    Meijer, Otto W. M.
    Vandertop, W. Peter
    Lagerwaard, Frank J.
    Slotman, Ben J.
    NEUROSURGERY, 2008, 62 (05) : A37 - A42